Free CME from PeerView


Neurology CME

Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Targeting BTK: The Latest Data on the Evolving Treatment Landscape for Patients With MS
Daniel S. Reich, MD, PhD
May 12, 2023
Credits: 1.0 CME / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Leveraging FcRn Modulation in Personalized Management of Generalized Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives to Achieve Treatment Goals
Vera Bril, BSc, FRCPC, MD
May 11, 2023
Anna Chodos, MD, MPH/Ian Neel, MD
Credits: 1.0 CME / MOC / NCPD / CPE / APA / IPCE
PVI, PeerView Institute for Medical Education
Facilitating Cognitive Assessment in Primary Care for the Timely Detection of Alzheimer’s Disease: Leveraging Medicare Reimbursement Mechanisms to Improve Clinical Care
Anna Chodos, MD, MPH / Ian Neel, MD
April 26, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Hope Is on the Horizon for Patients With ALS: Overcoming Diagnostic Difficulties and Exploring Novel Emerging Therapeutic Approaches
John Ravits, MD, FAAN
March 17, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
BTK Inhibition as an MS Treatment Modality: Where Do We Stand and Where Are We Headed?
Benjamin M. Greenberg, MD, MHS / Jiwon Oh, MD, PhD, FRCPC
March 15, 2023
Credits: 1.0 CME / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Revisiting the Role of Genetic Testing in Patients at Risk for Late-Onset Alzheimer’s Disease: How Will the Latest Evidence and Evolving Management Paradigm Impact Treatment Decisions for Your Patients?
Robert C. Green, MD, MPH
March 02, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Gearing Up for Plasma Biomarkers in the Clinic: Real-World Strategies to Facilitate the Timely and Accurate Neuropathological Diagnosis of Alzheimer’s Disease
Marwan Sabbagh, MD, FAAN
February 02, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Translating the Latest Research Advances Into Routine Care for Alzheimer’s Disease: Preparing Dementia Specialists With the Latest Strategies to Support Early Diagnosis and Comprehensive Care
Marwan Sabbagh, MD, FAAN
January 17, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Identifying Myasthenia Gravis and Assessing Patients’ Response to Treatment to Improve Outcomes
James F. Howard Jr., MD
December 29, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Revealing the Neuropathology of Alzheimer’s Disease Through Novel Fluid and Imaging Biomarkers: Ushering in a Precision Era of Diagnosis and Treatment
Val J. Lowe, MD / Jonathan E. McConathy, MD, PhD
November 28, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Setting Our Sights on Improved Outcomes in Glioblastoma: State-of-the-Art Care With Tumor Treating Fields and Other Innovative Approaches
Steven Brem, MD
November 18, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Moving Toward the Future in MS Management: What's the Latest on BTK Inhibition?
Jiwon Oh, MD, PhD, FRCPC
November 15, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
The Future Looks Bright for People With Fabry Disease: Improving Diagnosis and Expanding Treatment Options
David G. Warnock, MD
November 15, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Managing Disorders of Hypersomnolence: Reducing Patient Burdens, Protecting Patient Health
Richard K. Bogan, MD, FCCP, FAASM
November 04, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 24, 2022
Credits: 1.0 CME / NCPD / CPE
University of Florida College of Medicine
A Targeted Approach to Management of Generalized Myasthenia Gravis: The Latest on Novel Therapies That Improve Patient Outcomes
James F. Howard Jr., MD
October 02, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Encouraging News in Rett Syndrome: Steps Towards a Timely, Accurate Diagnosis and Treatment Breakthroughs
Jeffrey L. Neul, MD, PhD
September 14, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Optimizing Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy: Honing Diagnostic Accuracy, Personalizing Treatment Plans
David Cornblath, MD
July 21, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Therapeutic Advances in the Early Treatment of Alzheimer’s Disease: Expert Insights on Novel Biomarkers and Emerging Disease-Modifying Therapies
David Weidman, MD
June 20, 2022
PVI, PeerView Institute for Medical Education
Re-Examining S1PR Modulation From All Angles in Relapsing Multiple Sclerosis: Impact on Physical and Cognitive Outcomes, and Practical Considerations of Long-Term Therapy
Bruce Cree, MD, PhD, MAS
June 03, 2022
PVI, PeerView Institute for Medical Education
Innovations and Imaging in Multiple Sclerosis: Examining the Evidence, Looking Toward the Future of Bruton Tyrosine Kinase Inhibitors
Benjamin M. Greenberg, MD, MHS / Professor Anthony Traboulsee, MD
June 02, 2022
University of Florida College of Medicine
Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
Bruce Cree, MD, PhD, MAS
May 25, 2022
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
Joe R. Anderson, PharmD, PhC
May 06, 2022
Purdue University
Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Liana G. Apostolova, MS, MD, FAAN
March 18, 2022
Penn State College of Medicine
Leveraging S1PR Modulators to Provide Patient-Centered MS Care: An Expert-Driven Review of the Data
Mark S. Freedman, MD
February 28, 2022
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD
February 26, 2022
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
Gregory W. Albers, MD / S. Claiborne “Clay” Johnston, MD, PhD
February 11, 2022
Medical Learning Institute, Inc.
Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
Anita H. Clayton, MD
December 31, 2021

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView